Physician profile
Arpit Bhargava
NPI 1346550803
$2,506.43
in general payments reported to CMS, 2019-2025
21 companies · $642 in 2025
The $642 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.59 · 2020: $101 · 2021: $162 · 2022: $730 · 2023: $383 · 2024: $475 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,476 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.04 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $350.53 | 2020-2023 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $332.16 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $282.40 | 2021-2024 | |
| Medtronic, INC. | $262.45 | 2022-2023 | Ellipsys Vascular Access System |
| Amgen INC. | $208.96 | 2024-2025 | Krystexxa, Tavneos |
| Astrazeneca Pharmaceuticals Lp | $191.74 | 2021-2025 | Farxiga |
| Vifor Pharma, INC. | $178.31 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $138.67 | 2022-2025 | Acthar |
| Akebia Therapeutics INC | $81.86 | 2020-2024 | Vafseo, Auryxia |
| Opko Pharmaceuticals, LLC | $72.85 | 2022-2025 | Rayaldee |
| Travere Therapeutics, INC. | $69.49 | 2022-2023 | |
| Ani Pharmaceuticals, INC. | $63.76 | 2025 | Purified Cortrophin Gel |
| Lilly USA, LLC | $53.86 | 2024-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $50.21 | 2025 | Jynarque |
| Aurinia Pharma U.S., INC. | $40.70 | 2023-2024 | Lupkynis |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $24.20 | 2025 | Covera |
| Argon Medical Devices, INC. | $23.51 | 2024 | Clot Management |
| Mozarc Medical US LLC | $22.41 | 2024 | Chameleon |
| Cmp Pharma, INC. | $22.36 | 2021 | |
| Calliditas Therapeutics US INC. | $20.56 | 2024 | |
| Philips North America LLC | $15.44 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpit Bhargava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.